These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34706132)

  • 1. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
    Liu S; Jiang Z; Xiao P; Li X; Chen Y; Tang H; Chai Y; Liu Y; Zhu Z; Xie Q; He W; Ma Y; Jin L; Feng W
    Cancer Sci; 2022 Jan; 113(1):79-90. PubMed ID: 34706132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
    Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
    Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
    Chen Y; Wu Y
    Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
    Wang L; Li M; Lian R
    Histol Histopathol; 2022 Jul; 37(7):637-654. PubMed ID: 35133000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.
    Ying X; Zhu J; Zhang Y
    Mol Genet Genomic Med; 2019 Dec; 7(12):e991. PubMed ID: 31573758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
    Hayakawa D; Takahashi F; Mitsuishi Y; Tajima K; Hidayat M; Winardi W; Ihara H; Kanamori K; Matsumoto N; Asao T; Ko R; Shukuya T; Takamochi K; Hayashi T; Suehara Y; Takeda Nakamura I; Ueno T; Kohsaka S; Mano H; Takahashi K
    Thorac Cancer; 2020 Jan; 11(1):140-149. PubMed ID: 31758670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
    Makimoto G; Ninomiya K; Kubo T; Sunami R; Kato Y; Ichihara E; Ohashi K; Rai K; Hotta K; Tabata M; Maeda Y; Kiura K
    Jpn J Clin Oncol; 2021 May; 51(6):956-965. PubMed ID: 33829270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.
    Fan J; Xia X; Fan Z
    J Clin Lab Anal; 2022 Sep; 36(9):e24591. PubMed ID: 35908770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.
    Sun Z
    Life Sci; 2020 Oct; 259():118157. PubMed ID: 32735888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
    Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
    Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
    [No Abstract]   [Full Text] [Related]  

  • 12. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.
    Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W
    Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
    Wang Y; Yin L; Sun X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis.
    Shen HY; Shi LX; Wang L; Fang LP; Xu W; Xu JQ; Fan BQ; Fan WF
    J Transl Med; 2021 Sep; 19(1):389. PubMed ID: 34507559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
    Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
    Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578.
    Wang M; Ma M; Yang Y; Li C; Wang Y; Sun X; Wang M; Sun Y; Jiao W
    Thorac Cancer; 2021 Aug; 12(16):2258-2264. PubMed ID: 34236145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis.
    Ye Q; Li N; Zhou K; Liao C
    Mol Cell Biochem; 2022 Feb; 477(2):635-644. PubMed ID: 34988853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
    Han J; Wang Y
    Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
    Yu N; Gong H; Chen W; Peng W
    Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.